Accounting for dropout bias using mixed-effects models - PubMed (original) (raw)
. 2001 Feb-May;11(1-2):9-21.
doi: 10.1081/BIP-100104194.
Affiliations
- PMID: 11459446
- DOI: 10.1081/BIP-100104194
Accounting for dropout bias using mixed-effects models
C H Mallinckrodt et al. J Biopharm Stat. 2001 Feb-May.
Abstract
Treatment effects are often evaluated by comparing change over time in outcome measures. However, valid analyses of longitudinal data can be problematic when subjects discontinue (dropout) prior to completing the study. This study assessed the merits of likelihood-based repeated measures analyses (MMRM) compared with fixed-effects analysis of variance where missing values were imputed using the last observation carried forward approach (LOCF) in accounting for dropout bias. Comparisons were made in simulated data and in data from a randomized clinical trial. Subject dropout was introduced in the simulated data to generate ignorable and nonignorable missingness. Estimates of treatment group differences in mean change from baseline to endpoint from MMRM were, on average, markedly closer to the true value than estimates from LOCF in every scenario simulated. Standard errors and confidence intervals from MMRM accurately reflected the uncertainty of the estimates, whereas standard errors and confidence intervals from LOCF underestimated uncertainty.
Similar articles
- Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
Salim A, Mackinnon A, Christensen H, Griffiths K. Salim A, et al. Psychiatry Res. 2008 Sep 30;160(3):335-45. doi: 10.1016/j.psychres.2007.08.005. Epub 2008 Aug 20. Psychiatry Res. 2008. PMID: 18718673 - MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
Siddiqui O. Siddiqui O. J Biopharm Stat. 2011 May;21(3):423-36. doi: 10.1080/10543401003777995. J Biopharm Stat. 2011. PMID: 21442517 - A bias correction in testing treatment efficacy under informative dropout in clinical trials.
Kong F, Chen YF, Jin K. Kong F, et al. J Biopharm Stat. 2009 Nov;19(6):980-1000. doi: 10.1080/10543400903242753. J Biopharm Stat. 2009. PMID: 20183460 - Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
Woolley SB, Cardoni AA, Goethe JW. Woolley SB, et al. Pharmacotherapy. 2009 Dec;29(12):1408-16. doi: 10.1592/phco.29.12.1408. Pharmacotherapy. 2009. PMID: 19947800 Review. - An overview of practical approaches for handling missing data in clinical trials.
DeSouza CM, Legedza AT, Sankoh AJ. DeSouza CM, et al. J Biopharm Stat. 2009 Nov;19(6):1055-73. doi: 10.1080/10543400903242795. J Biopharm Stat. 2009. PMID: 20183464 Review.
Cited by
- Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy: A Randomized Clinical Trial.
Rosner R, Rau J, Kersting A, Rief W, Steil R, Rummel AM, Vogel A, Comtesse H. Rosner R, et al. JAMA Psychiatry. 2024 Nov 13:e243409. doi: 10.1001/jamapsychiatry.2024.3409. Online ahead of print. JAMA Psychiatry. 2024. PMID: 39535125 - Online eurythmy therapy for cancer-related fatigue: a prospective repeated-measures observational study exploring fatigue, stress, and mindfulness.
Timm E, Ko YM, Hundhammer T, Berlowitz I, Wolf U. Timm E, et al. Front Integr Neurosci. 2024 Sep 19;18:1472562. doi: 10.3389/fnint.2024.1472562. eCollection 2024. Front Integr Neurosci. 2024. PMID: 39364432 Free PMC article. - Long-Term Effects of Internet-Based Cognitive Behavioral Therapy on Depression Prevention Among University Students: Randomized Controlled Factorial Trial.
Nakagami Y, Uwatoko T, Shimamoto T, Sakata M, Toyomoto R, Yoshida K, Luo Y, Shiraishi N, Tajika A, Sahker E, Horikoshi M, Noma H, Iwami T, Furukawa TA. Nakagami Y, et al. JMIR Ment Health. 2024 Sep 24;11:e56691. doi: 10.2196/56691. JMIR Ment Health. 2024. PMID: 39319584 Free PMC article. Clinical Trial. - ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
Leisman DE, Handisides DR, Busse LW, Chappell MC, Chawla LS, Filbin MR, Goldberg MB, Ham KR, Khanna AK, Ostermann M, McCurdy MT, Adams CD, Hodges TN, Bellomo R; ATHOS-3 Investigators. Leisman DE, et al. Crit Care. 2024 Apr 18;28(1):130. doi: 10.1186/s13054-024-04910-6. Crit Care. 2024. PMID: 38637829 Free PMC article. Clinical Trial. - Changes in ocular blood flow in patients with neovascular age-related macular degeneration after intravitreal injection of ranibizumab biosimilar and brolucizumab.
Takizawa H, Yasuda M, Hoshi K, Okabe T, Kunikata H, Nakazawa T. Takizawa H, et al. Int Ophthalmol. 2024 Apr 16;44(1):181. doi: 10.1007/s10792-024-03107-8. Int Ophthalmol. 2024. PMID: 38625618
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources